Chandigarh: Weight-loss medicines have become increasingly common among people who are also being evaluated for fertility treatment. Many are prescribed by a different doctor, sometimes without any connection to the person’s fertility care, says Dr Parminder Kaur, Fertility Specialist, Birla Fertility & IVF, Chandigarh. This is relevant information for a fertility specialist, since these medicines can influence how an IVF cycle is planned, from the start of ovarian stimulation to the timing of pregnancy itself.
What Patients Should Disclose
The name of the medicine alone is not sufficient. A complete picture includes the exact medicine and dose, how often it is taken, when it was started and when it was last taken. Any weight lost since starting, along with changes in periods, appetite or other symptoms, should also be shared.
This information helps a fertility specialist understand a patient’s current hormonal and metabolic state before ovarian stimulation begins, and whether the treatment timeline needs to be adjusted.
Two Separate Timelines
There are two different reasons timing matters, and they are not the same.
The first concerns sedation. These medicines slow gastric emptying, and this effect does not end as soon as a dose is missed. Since egg retrieval is carried out under sedation, delayed gastric emptying can affect aspiration risk during the procedure. For this reason, many fertility teams ask patients to pause the medicine for a period before retrieval.
The second concerns pregnancy. These medicines are not recommended during pregnancy, and manufacturers generally advise a washout period after the last dose before conception is attempted. This period varies depending on the specific medicine, ranging from a few weeks to a few months.
A Change Patients May Not Expect
Some patients notice that their periods have become more regular after starting a weight-loss medicine, particularly when the original fertility concern was linked to insulin resistance. This can indicate that ovulation has resumed. At the same time, certain weight-loss medicines can reduce how consistently oral contraceptives are absorbed. Together, these effects mean a patient’s fertility status may change earlier than expected, which is why any recent change in cycles is worth mentioning at a fertility consultation, not only symptoms that feel medically significant.
Not a Decision for One Doctor Alone
Whether to continue, adjust or stop a weight-loss medicine before IVF should not be decided independently, either by the patient or by a single doctor. It should be a shared decision between the doctor managing the patient’s weight and the fertility specialist, based on the patient’s overall health, fertility goals, the specific medicine involved and how soon treatment is expected to begin.
Weight-loss treatment and fertility treatment are increasingly part of the same clinical picture rather than two separate conversations. A complete medication history, shared early, allows a fertility team to plan an IVF cycle around a patient’s actual current state, rather than adjusting the plan once treatment is already underway.
